lilly retatrutide Prepares for FDA Filing Following Additional Phase 3 Data in Diabetes, CVD Eli Lilly's Next-Gen Obesity Drug

Novo Nordisk introduces NovoCare Pharmacy, lowering cost of all doses of FDA-approved Wegovy (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients

For reference, the UK Summaries of Product Characteristics (SmPCs) for semaglutide (Wegovy) and tirzepatide (Mounjaro) both list injection site reactions including erythema, pruritus, and bruising as recognised adverse effects of their respective drug classes

Diabetologia 51(12):22632270

Environmental factor modification includes minimizing concurrent exposures that might increase neurological vulnerability

We demonstrate that these indole heterocycle libraries are amenable to screening so that new GLP-1 secretagogues can be identified

Medication is only one component of your plan